ABC drug transporter at the blood–brain barrier

Effects on drug metabolism and drug response
SPECIAL ISSUE

DOI: 10.1007/s00406-006-0664-4

Cite this article as:
Ebinger, M. & Uhr, M. Eur Arch Psychiatry Clin Neurosci (2006) 256: 294. doi:10.1007/s00406-006-0664-4

Abstract

At the blood–brain barrier (BBB) many cellular and dynamic mechanisms influence the cerebral drug metabolism and the drug response. In this review, we focus mainly on the role P-glycoprotein (P-gp) plays at the BBB. This protein is a 170-kDa ATP-dependent drug transport protein, located in the apical membrane of endothelial cells. Utilizing ATP hydrolysis as an energy source, it exports molecules which attempt to pass through the cell membrane from the outside to the inside, protecting cells from toxins and a wide range of substances. We briefly summarize some of the currently available in vivo and in vitro methods to investigate P-gp and its substrates. Hitherto, no chemical characteristic has been discovered that clearly distinguishes substrates from non-substrates of P-gp. We discuss some examples of substrates stressing the diversity of drugs and endogenous substances that relate to P-gp either as a substrate, an inhibitor, an inducer or as a combination of the above. Finally, we discuss genetic polymorphisms of the genes encoding for P-gp and their effects on drug response.

Key words

P-glycoprotein SNPs blood–brain barrier drug response 

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Max Planck Institute of PsychiatryMunichGermany

Personalised recommendations